Edinburg, TX – Dr. Robert Svatek, the Chair of Urology at UT Science Center at San Antonio (UTHSCSA) and one of the top five highest volume bladder cancer surgeons in the United States, visited DHR Health and DHR Health Institute for Research and Development to discuss collaborative efforts that will continue to enhance the ongoing partnership of advancing clinical care and research benefiting Rio Grande Valley residents.

“Dr. Robert Svatek is a nationally recognized urologic surgeon-scientist with clinical expertise in early and late phase clinical trials and urologic cancers” said Dr. Henry Ruiz, Medical Director at DHR Health Urology Institute. “Many areas of common clinical and research interests were discussed and we look forward to continuing to work with Dr. Svatek and his team at UTHSCSA to provide the highest level of care to members of our community”.

DHR Health Urology Insitute physicians with Dr. Svatek during visit. Left to Right: Dr. Henry Ruiz, Medical Director at DHR Health Urology Insitute, Dr. Robert Svatek, Chair of Urology at UTHSCSA, Dr. Gustavo Villegas, Dr. Maria Rodriguez, and Dr. Gaudencio Olguin.

DHR Health has endowed a Distinguished Chair in Urology at UTHSCSA. The primary objective of this endowment is to create a closer and more productive partnership between the institutions, which would benefit the Rio Grande Valley community. American Cancer Society has projected that over 248,000 patients will be diagnosed with prostate cancer in 2021 and more than 34,000 will have a fatal outcome. In addition, according to the Prostate Cancer Foundation, prostate cancer is the most commonly diagnosed cancer among Hispanic/Latino men in the United States.  

“Bladder cancer is also a serious clinical challenge in the Rio Grande Valley” said Dr. Sohail Rao, president and chief executive officer at DHR Health Institute for Research and Development.   “American Cancer Society has predicted that more than 83,700 patients will be diagnosed with bladder cancer in 2021 with a very high incidence (>20%) of fatal outcome.  Given Dr. Svatek’s interest in developing innovative strategies to treat bladder cancer, our goal is to work closely with his team at UTHSCSA to partner in these innovative clinical studies”.

For more information on research studies and collaborations, please contact Dr. Sohail Rao, president and chief executive officer at DHR Health Institute for Research and Development at (956) 362-2387 or visit www.dhrresearch.org.

About DHR Health for Research & Development


DHR Health Institute for Research & Development, affiliated with DHR Health, is a nonprofit organized under the Federal Internal Revenue Service Code 501(c)(3). DHR Health Institute for Research and Development leads the way for innovative, state-of-the-art clinical research in the Rio Grande Valley. To learn more visit our website at www.dhrresearch.org.

About DHR Health


DHR Health was founded in 1997 to help over 1.2 million residents resolve limited health care access challenges in a community that lacked public and county hospitals. Today, it is a modern, 500+ bed full-service health system serving over 280,000 patients annually, with 5500+ employees, over 650 physicians and more than 1,400 nurses dedicated to offering a full-continuum of care in over 70 different specialties and subspecialties. DHR Health proudly boasts the best specialty care in the region, a 24/7 functioning level-one trauma center, a robust clinical research division, and developing graduate medical education programs. DHR Health has revolutionized the health care landscape of the Rio Grande Valley and continues to raise the standard of care and transform the health care delivery model for the benefit all local residents. To learn more, visit our website at www.dhrhealth.com.